Figure 3

Classification results of the 'IRMA2' patient samples, classified with the CKD model [20]. A) Box-and-Whisker plot of microalbuminuric patients before (visit 2) and after two years (visit 9) treatment with 300 mg Irbesartan. The red line indicates the cut-off of the CKD model (classification factors above this cut-off are suffering from renal disease). B) Dot-and-line diagram of microalbuminuric patients before (visit 2) and after two years (visit 9) treatment with 300 mg Irbesartan. Classification factors of all patients, excepting patient no. 34, declined after Irbesartan intake. C) Box-and-Whisker plot of microalbuminuric patients before (visit 2) and after two years (visit 9) treatment with placebo. D) Dot-and-line diagram of microalbuminuric patients before (visit 2) and after two years (visit 9) placebo administration.